Studies of semaglutide in PWoH who were obese/overweight [25] or had T2D [26] report similar changes in levels of CRP during semaglutide treatment, and changes in CRP in these studies were related to changes in HbA1c and or body weight. The gene discussed is CRP; the disease is type 2 diabetes mellitus.